Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Improved methods and compositions for F-18 labeling of proteins, peptides and other molecules

An F-18, protein technology, applied in the direction of peptide/protein isotope introduction, drug combination, preparations for in vivo tests, etc., can solve the problems of burden and long time

Active Publication Date: 2011-07-13
IMMUNOMEDICS INC
View PDF81 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the half-life of F-18 is only 2 hours, so all the manipulations required to attach F-18 to a peptide is a significant burden
[0007] These methods are time-consuming and require the use of specially designed equipment to generate labeled products and / or the efforts of specialized chemists

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Improved methods and compositions for F-18 labeling of proteins, peptides and other molecules
  • Improved methods and compositions for F-18 labeling of proteins, peptides and other molecules
  • Improved methods and compositions for F-18 labeling of proteins, peptides and other molecules

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0106] Example 1. F-18 Labeling of Peptide IMP272

[0107] The first peptide used was IMP272:

[0108] DTPA-Gln-Ala-Lys(HSG)-D-Tyr-Lys(HSG)-NH 2 M H + 1512

[0109] Acetate Buffer Solution - Acetic acid 1.509g was diluted in ~160ml water and the pH was adjusted by adding 1M NaOH then diluted to 250ml to obtain a 0.1M solution at pH 4.03.

[0110] Aluminum acetate buffer solution: the aluminum solution is passed through 0.1028g of AlCl 3 The hexahydrate was prepared by dissolving in 42.6 ml DI water. A 4ml aliquot of the aluminum solution was mixed with 16ml of a 0.1M NaOAc solution (pH 4) to provide a 2mM Al stock solution.

[0111] IMP 272 acetate buffer solution: peptide 0.0011g, 7.28×10 -7 molIMP 272 was dissolved in 364 μL of 0.1 M pH 4 acetate buffer solution to obtain a 2 mM stock solution of the peptide.

[0112] F-18 labeled IMP 272: 3 μL aliquots of aluminum stock solution in REACTI-VIAL TM And mixed with 50 μL of F-18 (original sample) and 3 μL of IMP 272 sol...

Embodiment 2

[0136] Example 2. Immunoreactivity of F-18IMP 272

[0137] Peptides (16 μL of 2 mM IMP 272, 48 μg) were labeled with F-18 and analyzed for antibody binding by size exclusion HPLC. Size exclusion HPLC showed that the peptide bound hMN-14x679 but not to the irrelevant bispecific antibody hMN-14x734 (not shown).

Embodiment 3

[0138] Example 3. IMP 272F-18 Labeled with Other Metals

[0139] ~3 μL aliquots of metal storage solution (6×10 -9 mol) was placed in a polypropylene conical tube and mixed with 75 μL F-18 (original sample), incubated at room temperature for ~2 minutes, and then mixed with 20 μL of 2 mM (4×10 -8 mol) IMP 272 solution mixed. The solution was heated in a heater at 100° C. for 15 minutes and analyzed by reverse phase HPLC. IMP272 was labeled (not shown) with indium (24%), gallium (36%), zirconium (15%), lutetium (37%) and yttrium (2%).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present application discloses compositions and methods of synthesis and use of F-18 labeled molecules of use, for example, in PET imaging techniques. In particular embodiments, the labeled molecules may be peptides or proteins, although other types of molecules (including but not limited to aptamers, oligonucleotides and nucleic acids) may be labeled and utilized for such imaging studies. In preferred embodiments, the F-18 label may be conjugated to a targeting molecule by formation of a metal complex and binding of the F-18-metal complex to a chelating moiety (such as DOTA, NOTA, DTPA, TETA or NETA). In other embodiments, the metal may first be conjugated to the chelating group and subsequently the F-18 bound to the metal. In other preferred embodiments, the F-18 labeled moiety may comprise a targetable conjugate that may be used in combination with a bispecific or multispecific antibody to target the F-18 to an antigen expressed on a cell or tissue associated with a disease, medical condition, or pathogen. Exemplary results show that F-18 labeled targetable conjugate peptides are stable in human serum at 37 DEG C for several hours, sufficient time to perform PET imaging analysis.

Description

[0001] related application [0002] This application is a continuation-in-part of U.S. Patent Application No. 11 / 960,262, filed December 19, 2007, which requires U.S. Provisional Patent Application No. 60, filed January 11, 2007, under U.S.C. § 119(e) / 884,521, both of which are incorporated by reference in their entirety. technical field [0003] In certain embodiments, the present invention relates to a simple method of labeling peptides with F-18, which can be used for in vivo imaging. The preferred specific activity of the F-18 labeled peptide is about 1,000 to 2,000 Ci / mol when administered to a subject. Specific activities in the range of 100 to tens of thousands of Ci / mmol can also be used. While higher specific activity is preferred in certain imaging applications, in other alternatives lower specific activity NOTA (1,4,7-triaza-cyclononane-N,N',N "-triacetic acid) or another chelating moiety with a metal-F-18 complex, for example, a renal blood flow imaging agent o...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K51/00
CPCC07B59/008A61K51/08A61K51/088A61P43/00
Inventor W·J·麦克布莱德D·M·戈德堡
Owner IMMUNOMEDICS INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products